95% CI: 0.190.94
Insulin-Like Growth Factor-1 Regulates the SIRT1-P53 Pathway in Cellular Senescence
Thus, even if a doctor finds a hemorrhoid or anal fissure, he/she cannot be certain that they are the cause of the bleeding
GLP-1 Receptor Agonist Market Key Players Novo Nordisk A/S (Ozempic, Wegovy, Rybelsus, Victoza, Saxenda) Eli Lilly and Company (Mounjaro, Zepbound, Trulicity) AstraZeneca PLC (Byetta, Bydureon BCise) Sanofi SA GlaxoSmithKline plc Pfizer Inc

CrossRef Preclinical Studies on the Photothermal Therapy of NIRII AIEgens: Across Tumor Types Zijuan Meng, Xiaohua Ji, Shengyan Yin, Zhen Zhang, Ruihua Dong, Zheng Zhao, Ben Zhong Tang Small .2025;[Epub] CrossRef Liver biopsy in the modern era: from traditional techniques to artificial intelligence and multi-omics integration Nasar Alwahaibi, Maryam Alwahaibi Frontiers in Medicine .2025;[Epub] CrossRef Dual tissue mRNA and serum protein signatures improve risk stratification in hepatocellular carcinoma Ding-Fan Guo, Lin-Wei Fan, Qi Wen, Jin-Ke Wang, Yun-Hui Liang, Qi Feng, Ting Wang, Kun-He Zhang npj Precision Oncology .2025;[Epub] CrossRef 12,900 View 328 Download 17 Web of Science Crossref Original Article Steatotic liver disease Abstract PDF Supplementary Material Background/Aims With the obesity pandemic, metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease and a leading cause of end-stage liver disease and liver-related deaths in the USA

I've added the 7% to my super cp serum and I love the result